ImmunoGen Announces Conference Call to Discuss Its First Quarter 2017 Financial Results

08:30 EDT 21 Apr 2017 | Businesswire
This article has expired, however you can still download the PDF.
ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, May 5...

Other Sources for this Article

For Investors
Thrust IR
Monique Allaire, 617-895-9511
For Media
FTI Consulting, Inc.
Robert Stanislaro, 212-850-5657


More From BioPortfolio on "ImmunoGen Announces Conference Call to Discuss Its First Quarter 2017 Financial Results"

Quick Search

Relevant Topics

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...